ESC Rome 2016

Area: Cardiology

Location: Rome, Italy

Date: August 27 to August 31

Description:

European Society of Cardiology Congress


Search in Scientific Content:
Date
Filters:
Prevention
5:29

Prevention and Lipids - The effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease

Presenter: Brian A. Ference
Cardiology
Prevention
4:07

Prevention and Lipids - OPTICARE - Benefits of the OPTImal CArdiac REhabilitation trial: an expanded educational and behavioral intervention

Presenter: Ron T Van Domburg
Cardiology
Prevention
5:37

Prevention and Lipids - 2016 ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Presenter: Patrick Moriarty
Cardiology
Prevention
6:26

Prevention and Lipids - Apheresis as a novel treatment for refractory angina with raised lipoprotein(a): a randomised controlled trial

Presenter: Tina Zubaida Khan
Cardiology
Coronary A
5:49

Coronary Artery Disease and Imaging - CONSERVE - Direct catheterization versus selective catheterization guided by Coronary CT in patients with stable suspected Coronary Artery Disease

Presenter: Hyuk Jae Chang
Cardiology
Coronary A
4:44

Coronary Artery Disease and Imaging - CE-MARC 2 - A randomized trial of 3 diagnostic strategies in patients with suspected coronary heart disease

Presenter: John P. Greenwood
Cardiology
Coronary A
6:38

Coronary Artery Disease and Imaging - AMERICA - Systematic detection and management of multivascular involvement of atherothrombosis in coronary patients in comparison with treatment of coronary disease only

Presenter: Jean-Philippe Collet
Cardiology
Heart Fail
4:44

Heart Failure and Innovative Approaches - DANISH -assessing the efficacy of ICD in patients with non-ischemic systolic heart failure

Presenter: Lars Kober
Cardiology
Heart Fail
4:08

Heart Failure and Innovative Approaches - REM-HF - Remote monitoring: an evaluation of implantable devices for management of heart failure patients

Presenter: Martin R. Cowie
Cardiology
Heart Fail
7:04

Heart Failure and Innovative Approaches - MORE-CARE - Effects of remote monitoring and use of healthcare resources in HF patients with biventricular defibrillators

Presenter: Giuseppe Boriani
Cardiology
Heart Fail
5:23

Heart Failure and Innovative Approaches - CHART-1 - Phase 3 congestive heart failure cardiopoietic regenerative therapy

Presenter: Jozef Bartunek
Cardiology
Heart Fail
6:38

Heart Failure and Innovative Approaches - Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells

Presenter: Javed Butler
Cardiology
Preventive
7:04

Preventive Strategies I - ANTARCTIC - Platelet function monitoring in elderly patients stented for an acute coronary syndrome

Presenter: Gilles Montalescot
Cardiology
Preventive
5:32

Preventive Strategies I - NIPPON study: Optimal DAPT duration following drug eluting stent

Presenter: Masato Nakamura
Cardiology
Preventive
5:49

Preventive Strategies I - SAVE - The sleep apnea cardiovascular endpoints study results

Presenter: Doug McEvoy
Cardiology

Preventive Strategies I - NACIAM Trial - The early use of NAC with GTN in ST-segment Elevation MI patients undergoing PCI

Presenter: Sivabaskari Pasupathy
Cardiology
ANNEXA-4 S
4:36

ANNEXA-4 Study; new antidote against Factor Xa inhibitors

Presenter: John William Eikelboom
Cardiology
Imaging of
6:05

Imaging of the heart: cardiac CT - indication, specificity, sensitivity, radiation dose, screening.

Presenter: Pal Maurovich-Horvath
Cardiology
The New He
14:20

The New Heart Failure Guidelines

Presenter: Petros Nihoyannopoulos
Cardiology

Daily use of the specific antidote of dabigatran

Presenter: Charles V. Pollack
Cardiology

Game changing results in the field of ICD and cardiopoetic stem cell therapies

Presenter: Frank Ruschitzka
Cardiology
Where are
4:43

Where are we going with the NOAC-s; dabigatran's specific antidote

Presenter: John William Eikelboom
Cardiology
Unfavourab
2:51

Unfavourable outcome after the upgrade of an implantable cardioverter defibrillator to cardiac resynchronization therapy

Presenter: Marcell Clemens
Cardiology
How long s
2:55

How long should we anticoagulate after pulmonary embolism

Presenter: John William Eikelboom
Cardiology

Prevention:the role of hypertension, and high lipid levels

Presenter: Joep Perk
Cardiology

Indepth analysis of the patient survival from the Hungarian Myocardial Infarction Registry and its role in the choice of anti-platelet agent.

Presenter: Andras Komocsi
Cardiology

Causative effect of LDL-C and sistolic bloodpressure in CV risk. Role of preventive strategies

Presenter: Brian A. Ference
Cardiology

Novelties about coronary artery disease and imaging technologies

Presenter: Michael Haude
Cardiology
Summary of
2:01

Summary of the Preventive Strategies II. Hotline Session

Presenter: Stuart J. Connolly
Cardiology
Summary of
7:34

Summary of the Preventive Strategies Hotline Session

Presenter: Stephan Gielen
Cardiology

Anticoagulant therapy with NOACs in AF and VTE; Dealing with patients with comorbidities

Presenter: Harald Darius
Cardiology

Novelties in the field of Coronary Artery Disease and Stenting

Presenter: Andreas Baumbach
Cardiology

AHA 2018

2018-11-10 - 2018-11-12
Chicago, United States

ESC 2018

2018-08-25 - 2018-07-29
Munich, Germany

ESC Heart Failure 2018

2018-05-26 - 2018-05-29
Vienna, Austria

ACC 2018

2018-03-10 - 2018-03-12
Orlando, United States

ESC 2017

2017-08-26 - 2017-08-30
Barcelona, Spain

ACC 2017

2017-03-17 - 2017-03-19
Washington DC, United States

AHA 2016

2016-11-13 - 2016-11-16
New Orleans, United States

AHA 2015

2015-11-07 - 2015-11-11
Orlando, United States

ESC 2015

2015-08-29 - 2015-09-02
London, United Kingdom